Breast Diseases  >>  Halaven (eribulin mesylate)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Halaven (eribulin mesylate) / Eisai
ESKIMO, NCT01961544: Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer

Completed
4
101
RoW
Eribulin mesylate
Eisai Korea Inc.
Breast Neoplasms, Breast Cancer
07/15
07/15

Download Options